Advanced Search
Submit ManuscriptADVANCE ONLINE PUBLICATION
Mitochondrial double-stranded RNA drives aging-associated cognitive decline
Lixiao Zhang1,† , Xiang Li1,† , Hongdi Luo1,† , Yujia Huo1 , Guangkeng Zhou1 , Pengcheng Wang1,2 , Sipeng Wu1 , Xinyong Lin1 , Kai Dai3 , Jiahao Shi1 , Zebao Wang1 , Jiaxin Xu1 , Renjian Li1 , Siyi Chen1 , Zhe Sun1 , Chunlin Zhao1 , Zizhuo Zhou1 , Zhenhong Wang1 , Chensi Liang4 , Jun Zhu1 , Xingjun Chen1 , Jintao Luo1 , Yong Yu1 , Zhirong Zhang1,* , Geng Wang1,5,*
1State Key Laboratory for Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian, ChinaAging is the primary cause of cognitive decline. Despite extensive study, the molecular mechanisms driving aging-associated cognitive decline remain unclear. Here, we describe a proteostasis-independent function of SEC61A1 and its involvement in aging-associated cognitive decline. SEC61A1 regulates ER–mitochondria contact sites, affecting mitochondrial DNA and RNA synthesis and subsequently leading to changes in innate immune signaling mediated by mitochondrial double-stranded RNA (mt-dsRNA). This pathway is activated in aged wild-type mice, Alzheimer’s disease patients, and 5×FAD mice. Tissue-specific overexpression of Sec61a1 in the mouse cortex (Sec61a1Tg) is sufficient to induce cognitive decline without affecting motor activity. Knockdown of Sec61a1 or Mavs ablates mt-dsRNA-mediated innate immune signaling and alleviates cognitive decline in naturally aging wild-type mice. These results reveal a molecular mechanism of aging- and disease-associated cognitive decline and provide a potential therapeutic tool for intervention.
https://doi.org/10.1038/s41422-026-01224-w